![]() |
Trials |
A phase Ib/II, multicenter, open-label study of EGF816 in combination with INC280 in adult patients with EGFR mutated non-small cell lung cancerCancer type: Lung cancer Phase: I/II Principal Investigator: Sprauten Mette Country: NO Keywords: Norway, Oslo, NSCLC, EGFR mutated Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02335944?term=cinc280x2105c&rank=1 |